Pod Insights Pharmacy Podcast Network The Compounding AI Primer Episode | Essential; Pharmacy Compounding Podcast APC About this episode This week we look at a somewhat confusing, possibly problematic FDA statement, as well as the anti-compounding bills popping up across the country. Our Deep Dive this week is a hot topic: AI in pharmacies — how it’s being used successfully, but also how you can use it to streamline your workflow and, yes, even increase your bottom line. Our expert will tell you what to look for, and what easy pitfall you need to avoid. Links from the podcast: The troublesome FDA statement: https://fllw.me/4utzQIw APC’s Snapshot of Pharmacy Compounding: https://a4pc.org/snapshot Read more about the 2002 Supreme Court case "Thompson v. Western States Medical Center": https://www.oyez.org/cases/2001/01-344 TJM Labs: https://tjmlabs.com Join APC: https://a4pc.org/join
Transcript 0:05 Speaker 00 You are listening to the global network of podcasters dedicated to the pharmacy profession. Welcome to the pharmacy podcast network.
0:26 Speaker 01 Welcome back to Essential, the pharmacy compounding podcast with the latest news and analysis from you know it, the Alliance for Pharmacy Compounding, the voice for pharmacy compounding. I'm your host, Andrew Cantor. We're going to give you a bit of pharmacy compounding news before we get to the main event. That's when we're going to talk about artificial intelligence and how it fits into compounding pharmacy in 2026. We've got an expert here to answer our questions without getting too geeky about it, but that's in a minute. First, the news.
1:01 Speaker 01 The FDA released a bit of a double whammy statement that not only got compounders confused, lawyers who know this stuff don't know what the FDA is thinking. The big picture is that the agency seems like it's going to be turning its eye to GLP-1 compounding, kind of like Sauron, but without the orcs. So the first whammy from this, this statement, the agency said it's going to start cracking down on the use of GLP-1 APIs by compounding pharmacists. What legal ground the agency has for limiting a particular ingredient, it's just not clear. I mean, it's likely because of pressure from the big drug makers, but the question is,
1:42 Speaker 01 how is the FDA going to do it? It's got a limited toolset. So whatever it does, it's going to have to be a lengthy process, like, I don't know, creating a demonstrably difficult to compound list, which it hasn't done yet, and then adding GLP-1s to it, and neither of those are easy or slam dunks. All right, whammy number two. In the same statement, the agency said that it's going to crack down on companies, quote unquote, "mass marketing of GLP-1 drugs." Among other things, it said it would prevent compounders from saying in their ads that their compounded formulations use the same active ingredients as the FDA-approved drugs.
2:24 Speaker 01 The thing is, they do use the same ingredients. That is a truthful statement. It has to be, or they couldn't compound the substance in the first place. Being a component of an FDA-approved drug is a criteria for compounding. That's right out of the Food, Drug & Cosmetic Act. And that's why there are lawyers scratching their heads at the logic, or lack thereof. And now there are some new twists. I was kind of surprised, but after those FDA statements, Novo Nordisk reached an agreement with HIMSS and HERS. Now HIMSS will be able to dispense Novo's Ozempic and Wegovy, the FDA-approved versions, and in exchange, it agreed not to market its compounded GLP-1s.
3:09 Speaker 01 Market is the key word here. HIMSS will still be able to dispense the compounded versions, just not market them. So I guess that was Novo's problem after all, marketing. Because it once, once it reached the agreement with HIMSS, Novo dropped its patent lawsuit. And this raises a question about the FDA's potential crackdown on GLP-1 marketing. Now we know that Novo's issue wasn't production and dispensing of GLP-1s that are compounded, but the mass marketing of them. So is that the same issue the FDA has? Will the agency back down? And what does that say about industry influence? But wait, there's another wrinkle.
3:52 Speaker 01 Sure, the FDA can absolutely crack down on false or misleading marketing, no argument. But it doesn't have the power to prohibit mass marketing, whatever that means. The Supreme Court said so back in 2002 in what was known as the Thompson case. The FDA, it ruled, can't broadly prohibit marketing of compounded therapies as long as that marketing is truthful. There's a link to the case in the show notes. Besides, who is supposed to decide what is mass marketing? It doesn't matter. The court said FDA can't prohibit it. Obviously, this whole issue is something blinking bright on our radar. So stay tuned for updates in probably the next few weeks.
4:37 Speaker 01 What, you might wonder, does the world of pharmacy compound look like today? Glad you asked. APC just released the latest version of its Snapshot of Pharmacy Compounding, the 2026 version, and the title kind of says it all. It is a demographic profile, a slick little PDF that outlines the most important stats about pharmacy compounding in the U.S. The idea is, we want you to download it and share it with lawmakers and the media and prescribers, even patients. Get the word out about how important pharmacy compounding is and how much it helps patients. Not everyone knows this stuff, especially if they're getting their info from the big pharma companies.
5:18 Speaker 01 For example, did you know that the typical compounding pharmacy will dispense something like 350 compounded prescriptions a week? Or that the typical outsourcing facility provides jobs for 30 people? Yeah, there's a link to download the Snapshot in the show notes, so grab it, check it out, and then share it far and wide.
5:41 Speaker 01 There's been a disturbing trend popping up in one state after another. Pushed by the big drug companies, state legislators are introducing bills that would add all sorts of new restrictions on pharmacy compounding. They're being pitched as bills to protect patients, but let's be honest, that is not what they're about. They're all about security theater, and they come at the expense of pharmacists who have a whole extra set of burdens that, well, they won't make anything safer. But more importantly, these restrictions are going to hurt patients who rely on compounded meds, and we know there are a lot of those. APC has been fighting these bills one at a time, and the good thing is, we've been winning.
6:21 Speaker 01 We've helped kill bills in, let's see, Florida, Virginia, Arizona, Washington State, Mississippi, and a couple others. But like I said, these bills are popping up all over, so we're working pretty hard and doing a lot of lobbying. As I read the script, there are still anti-compounding bills in a bunch of other states, so the fights continue. It's like whack-a-mole, but with lives at risk, so no fun. And with that, it is time for our deep dive.
6:54 Speaker 01 Today, we've got a hot topic for our deep dive: Artificial Intelligence and Pharmacy. We've got with us Jonathan Adley. He's the founder of TJM Labs. He's an expert in AI and software development. And while he's here today, he is also immersed in clinical pharmacy. Now, we don't want to talk too much about the pie in the sky stuff. Jonathan's here to talk about the practical realities of AI in pharmacy. Thanks for coming here, Jonathan.
7:22 Speaker 02 Thanks for having me, Andrew. Love what Alliance of Pharmacy Combining does for the Combining community. And these are exactly the conversation that we need to have in right now.
7:31 Speaker 01 Well, I think a lot of industries are having this conversation about AI and how it fits in whatever they're doing. And I want to be clear, we're going to focus on where AI is actually being used in pharmacies today, not just speculating on what might happen in five or 10 years. Well, we'll do a little of that. But let me start with a softball. Give me an idea of some real world, practical uses for AI in pharmacy today. Let's talk improving efficiency and accuracy.
8:03 Speaker 02 Yeah, sure. I'll give you a concrete example. There is a very large Combining pharmacy in Texas, a serial acquirer. They have bought up several other pharmacies over the last few years. Their whole business model is margin efficiency. Buy a pharmacy, tie in the operation and grow it. The bottleneck for them was always prescription data entry. It is tedious, it is high volume, and every person you put on it is a person you are paying to do something a computer could do. They have now automated about 95% of the prescription data entry using AI bots. Think about what that unlocks.
8:44 Speaker 02 You're not just saving on labor costs, you're removing a variable that causes error. A bot does not get tired at the end of a double shift. It does not make typos because it's been staring at a screen for eight hours. It works 24/7, nonstop. And this is happening today, not five years from now, not, you know, 10 years from now. The promise of AI in pharmacy is not in theory. It is a compounding pharmacy like the one I just talked about, running a super scalable business because they made that bit early.
9:17 Speaker 01 Well, there's a lot of news like that about AI. And you gave me a perfect example of something that's real. But it is easy to get lost in what's real and what's just, you know, the hype of the day. So, clear it up for us. What are the most common misconceptions that pharmacy leaders and pharmacists and technicians have about AI?
9:42 Speaker 02 Yeah, so we consistently hear from the owners that it is more complicated to deploy than it is. It's not, right? It is, I would say, at this point, it's been two years when AI really came to the scene. It is a well-oiled machine. From the technician's side, there's a lot of fear that it's coming for their jobs. The reality is, the techs who embrace AI become more valuable, not less. They move up, they supervise the automation, and they do higher complexity work.
10:11 Speaker 01 Now, we've heard that before. We've heard that in a lot of industries, and in many cases, it's true. But is there a risk of jumping into AI just because you think you should? I'll give you an example. My favorite coffee roaster, I order from them online, and they started using an AI to contact me every time I place an order. Now, there's no reason for a coffee roaster to have an AI. But they do because someone there decided, oh, AI is hot, we should have one. So, how should pharmacies be thinking about AI so they actually accomplish something and don't just have it for the sake of having it?
10:52 Speaker 02 You're 100% right. Everyone today is labbing AI in everything. That coffee bot probably annoyed you more than it helped you. And that's actually a useful filter. I think about AI in pharmacies through three buckets. And if something does not fit cleanly into one of them, you probably do not need it. Bucket number one, the fun bucket. This is a chatbot on your website, an AI that answers some basic patient questions. It's an AI that makes nice marketing photos, pictures. It's nice, patients appreciate it. It's not really moving the needle on your business. It's fine to have, but do not confuse it for transformation. Bucket number two is AI that saves you money.
11:35 Speaker 02 This is where compounding pharmacies should be paying the most attention right now. Data entry automation, prescription processing, refill management, tasks that are high volume, repetitive and eat technicians hours. This is proven deployable today and the return of investment is very measurable. Bucket number three is AI that makes you money. And this is, I would say, newer territory. This is an AI that helps you expand what you can offer. Think about a pharmacy that now has the capacity to consult and personalize hormone protocols because the admin burden had been lifted. Or an AI that helps you practice at a higher level and capture revenue that you're leaving on the table today.
12:20 Speaker 02 Most vendors, when we talk about AI, they really are selling you bucket number one and, you know, hyping it up and saying it's a revolution. But the real opportunity is bucket number two and bucket number three.
12:31 Speaker 01 I can't imagine anyone complaining about bucket number two and bucket number three, saving money, making money. So let's get more specific. Where are you seeing AI deliver real improvements for pharmacies? You mentioned the one in Texas. So in general, how does AI improve pharmacy workflows?
12:52 Speaker 02 Yeah, so I'd say, you know, data entry and prescription processing by a wide margin. That's where most of the volume is. This is where the errors happen. And this is where the AI can truly earn its keep the fastest.
13:05 Speaker 01 Okay, now, we've talked about errors and people have heard. Anyone who's read about AI knows that it can make mistakes. And of course, that's what gets covered in the news. What do you say to a pharmacist who's, I don't know, they're a little reluctant to use AI because of the stuff that they read about the general, the LLMs, the chat GPTs out there? Is there a good place for a pharmacist to start to, I don't know, give AI a trial run?
13:38 Speaker 02 Honestly, you know, pharmacy is probably the best environment to deploy AI, precisely because of that skepticism. Here's what I mean. In most industry, when an AI makes a mistake, it means someone has to go out of their way to catch it. And there is no guarantee that anyone will. In pharmacy, that catch mechanism is already baked in the regulation and all the workflows. Every step has a pharmacist verification and checkpoint. That does not go away when you add AI. AI does the work and the pharmacist still verifies. So for the skeptic, this is what I would say. You're not being asked to trust AI blindly.
14:21 Speaker 02 You're being asked to let AI handle the data entry and you do what you have always done. Review and sign off. You're not removing the human from the loop. You're removing the human from the boring part of the loop. A good place to start is your highest volume, lowest complexity task in your workflow. I would say, you know, for most pharmacies, data entry is the obvious one. Run it in barrel with your existing process for a week or two. The day I do it, have your technician check it before it even goes to the pharmacist for another check. And you'll see very quickly whether it's earning your trust or not.
15:02 Speaker 01 So you talk about the current workflow and the regulations now that everything has to be checked. So yeah, it absolutely makes sense to have humans, pharmacists, checking the work. So there have to be places where you can't use an AI. You know, where the human judgment is more than just checking AI work, but where humans are front and center.
15:29 Speaker 02 Yeah, clinical decisions, full stop. Anything that touches patient safety, drug interactions, compounding formulations, that stays with the pharmacist. I like to say AI is not, is an operator, not a clinician.
15:46 Speaker 01 All right. So let's say you've decided you're going to make the leap to using AI. This is another question that comes up a lot. How do you tell which products out there are good and which are just hype? Which is the coffee roaster bot that doesn't help me at all? It's not like, you know, there's a subreddit you can ask for advice on something that's technical. Actually, wait, before you answer that, how about this? Before you start to look at different AI tools for a pharmacy, what do you need to think about when you're looking at your whole operation?
16:23 Speaker 02 Yes, I would say workflow clarity. If your process is chaotic, there is no organization, AI will automate the same chaos. So the first thing you need to do is get your standard operating procedures right. Know what your highest volume tasks are. Once you have that in place, then bring the AI to handle them.
16:46 Speaker 01 All right, that makes perfect sense. So, all right, you have an idea of where you want to use AI, where it can do the most for you. Tell me, how do you tell which AI tool is the right one? Because there are a lot out there.
17:02 Speaker 02 Yeah, the best filter that I have personally found is specificity. So generic AI, when you apply that to a pharmacy, that's a red flag. A vendor who truly understands combining workflows, who can speak to the difference between a pioneer and a live file implementation, who has been inside actual combining pharmacies and seen the madness, that is a different conversation. I would say, you know, look for vertical specific software built by people with domain expertise. It's the same way why you wouldn't hire a generalist consultant to advise you on 503B compliance. You want someone who lives in that world. The other
17:43 Speaker 02 filter is old fashioned references, you know, not testimonials on a website, actual pharmacies you can call and ask. Did this work? What broke? What surprised you? If, you know, a vendor you talked to and they cannot give you three pharmacy owners to call, that tells you something. There is also a community forming around this. You know, Alliance of Pharmacy Combining is actually a great example. These conversations happen organically in conferences, in to be a group. So, you know, your compounding colleagues who have made the leap, who took that risk for you, are probably the best diligence tool as of today.
18:21 Speaker 01 And I think that's important because we hear a lot about ChatGPT and Claude and whatever's coming next. But these are the generalist tools that college kids can use to help write their essays. And the idea that looking for specific tools that are geared towards pharmacies, towards compounding pharmacies is critical. Before we go, I want to take a one, one quick trip into the future, say five years down the line. There's an obvious question, what role are pharmacists going to play as AI gets more integrated? How, how is their workload going to change?
19:03 Speaker 02 Yeah, the pharmacist is not going anywhere, but the job is going to look very different. And I think better. Right now, a lot of the pharmacist's time is spent on things that does not require a pharmacist's training. Data entry, insurance calls, routine refills, AI will take all of that. Not because pharmacists cannot do it, but because it's a waste of their expertise. Five years from now, the pharmacist's time will get redirected to the work that actually require their judgment and expertise. And compounding is a perfect example of where that matters. You know, take hormone replacement service, for example. There are one of the fastest growing areas right now, and they are complex.
19:46 Speaker 02 Most pharmacies I talked to are not capturing the full opportunity because they don't have the bandwidth to probably talk to patients about it. Think about a personalized protocol, dosing, cycling, stacking. That require personalized clinical judgment and a lot of clinical knowledge. That requires a pharmacist who had the time to actually sync and consult with these patients. AI creates that time. The pharmacist who in five years is spending their day on clinical consultations or provider relationships or on complex formulation questions. That pharmacist is practicing at the top of their license. That is a more fulfilling career and it's also a better business.
20:32 Speaker 01 That is terrific. Well, in just a few minutes, we have covered a lot of ground today. And we've taken a bunch of your time, Jonathan. I know you're really busy. Thank you for sharing, sharing what you've learned, sharing what you've seen, what you know. It is not an easy topic. It's not something that we can cover in just a podcast and it's not something that you should just use this podcast as, you know, you're jumping off point, but it's certainly a start and hopefully we've given people things to think about. The whole topic, it's, it's not easy and we are lucky to have you here. Speaking of which, we will put a link in the show notes to where people can find out more about you and TJM Labs. So thanks for taking the time.
21:17 Speaker 02 Thank you.
21:18 Speaker 01 Well, all right. That is it for this episode of Essential. But before we play the outro music, there's something I always point out. If you are a compounding pharmacist or a technician, or if you prescribe compounding meds, APC is almost certainly helping you and helping your patients. We gave you some examples earlier. I'm not going to go through everything APC does, but I will say it is the biggest and in a good way, the loudest trade association for the whole compounding profession. If you're not a member of APC, you ought to be. We're working for you and we'd love to have you on board. Just head over to a four P C dot org. That's A, the number four, P C dot org. Check us out. All right, now we can play that outro music.
22:03 Speaker 01 Thank you for listening.
Previous The Pennsylvania Pharmacist Association's Annual Conference Post Show | Part Two Next The Pennsylvania Pharmacist Association's Annual Conference Post Show | Part Three (Finale) Page updated November 14, 2026 · transcript and summary are machine-generated